CAPR - This is a fantastic chart from the FDA deramiocel review, showing how unauthorized changes to the HOPE-3 study statistical plan led t
CAPR - This is a fantastic chart from the FDA deramiocel review, showing how unauthorized changes to the HOPE-3 study statistical plan led to dramatic increases in statistical significance. If your study delivers negative results, change the way you analyze the results! -- ADAM F STAT
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.